QWQianlin Wang

Qianlin Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Qianlin Wang has a total of 40 co-authors. Here are the top co-authors by number of shared publications:

  • Pengmei Li

    Department of Pharmacy China‐Japan Friendship Hospital Beijing China

    2 shared publications
  • Wenqian Chen

    Department of Pharmacy China‐Japan Friendship Hospital Beijing China

    2 shared publications
  • Xianglin Zhang

    Department of Pharmacy China‐Japan Friendship Hospital Beijing China

    2 shared publications
  • Zhan Dou

    College of Mechanical and Electrical Engineering, Beijing University of Chemical Technology, Beijing 100029, China

    2 shared publications
  • Chen Wang

    Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, National Clinical Research Center for Respiratory Diseases, Beijing, China

    1 shared publication
  • Chen Wang

    China-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

    1 shared publication

Latest Publications

  • Open Access

    Effect of Regulating FUNDC1 Mitophagy‐Mediated cGAS/STING Pathway in Oleic Acid‐Induced Acute Lung Injury Model

    by Liangyu Mi, Yuankai Zhou, Wenyan Ding, Xiangyu Chen, Yingying Yang, Qianlin Wang, Lu Wang, Longxiang Su, Yun Long

    Acute lung injury (ALI) involves inflammatory cytokines and chemokines, resulting in lung and multiple organ injuries. This study explored the mechanism of mitophagy and cGAS/STING pathway in oleic acid (OA)‐induced ALI. Mice and pulmonary microvascular endothelial cells were divided into four groups: control group (Con), ALI group, FUNDC1−/− control group (F‐Con), and FUNDC1−/− ALI group (F‐ALI). After 24 h of modeling, proceed with tissue collection. Lung tissues were stained using hematoxylin eosin. Autophagosomes were observed by electron microscope and mtDNA was detected by qPCR. Western blot was used to analyze protein expression of pathways cGAS, STING, pTBK1, pIRF3, and pNF‐κB. Serum IFN‐β expression was detected by ELISA. Cellular morphological changes were observed using microscopy. LDH level, cGAS, and STING in endothelial cells were observed. Compared with control group, pathological changes in ALI group were significantly aggravated. Expressions of serum IFN‐β, cGAS, STING, pTBK1, pIRF3, and pNF‐κB in lung tissues of ALI mice were significantly higher than control group. After OA, the morphology of lung microvascular endothelial cells changed and LDH expression increased. After FUNDC1 gene was knocked out to inhibit mitophagy, autophagosomes were significantly reduced and mtDNA increased. Expressions of pathway proteins in lung tissues and cells of FUNDC1−/− ALI group were higher than those of wild‐type ALI group. Serum IFN‐β expression also increased. Silencing FUNDC1 inhibits mitophagy. Subsequently, accumulated mtDNA activates cGAS/STING pathway, aggravating ALI pathological damage and inflammation, suggesting that mitophagy may provide protection in OA‐induced ALI through cGAS/STING pathway.


  • Open Access

    Early bedside detection of pulmonary perfusion defect by electrical impedance tomography after pulmonary endarterectomy

    by Qianlin Wang, Huaiwu He, Siyi Yuan, Jing Jiang, Yi Chi, Yun Long, Zhanqi Zhao

    Pulmonary endarterectomy (PEA) is the standard treatment for chronic thromboembolic pulmonary hypertension. However, it poses risks of perioperative vascular complications, which can lead to serious clinical outcomes. This study introduces a novel noninvasive and radiation‐free clinical imaging tool, electrical impedance tomography (EIT), for real‐time bedside assessment of lung perfusion after PEA. It identifies ventilation‐perfusion mismatches arising from postoperative complications, particularly valuable for patients with hemodynamic instability, thus eliminating risks tied to CT room transfers. The article reports a case where EIT was used to identify an in‐situ thrombosis post‐PEA, marking the first such application. The emphasis is on early detection using EIT, which offers a promising approach for therapeutic interventions and improved postoperative evaluations.


  • Process alarm log mining and modeling based on complex networks

    by Yingqi Zhu, Qianlin Wang, Dongsheng Zhang, Jiaqi Han, Zhan Dou, Jianwen Zhang

    To analyze the correlation between alarm logs generated during complex chemical processes, a mining and modeling method of process alarm logs is proposed in this paper. The proposed method mines the correlation between alarm logs based on the Word2Vec and Pearson correlation coefficient, and establishes a quantitative modeling based on the complex networks. Firstly, the alarm variables are mapped to real-valued vectors using the Word2Vec. Then, the association relationships among the alarm logs are analyzed using the Pearson correlation analysis, and the Pearson correlation coefficient matrix and its Boolean matrix are obtained. The Boolean matrix is set as the adjacency matrix, and complex networks can be quantitatively modelled. Finally, the effectiveness of the proposed method is verified by an actual case.

  • The population pharmacokinetics and dose optimization of polymyxin B in critically ill patients with or without extracorporeal membrane oxygenation

    by Qinghua Ye, Qianlin Wang, Wenqian Chen, Ruihao Zhang, Ziying Chen, Pengmei Li, Xianglin Zhang, Qingyuan Zhan, Chen Wang

    The presence of extracorporeal membrane oxygenation (ECMO) is suggested to further exacerbate the pharmacokinetics (PK) alterations that occur during critical illness. The objectives of this study were to determine the population PK model of polymyxin B in critically ill patients with or without ECMO support investigated the influence of ECMO on PK variability and to identify an optimal dosing strategy. Forty-four critically ill patients were enrolled, including eight patients with ECMO support. Eight serial serum samples were collected from each patient at steady state. The population PK was determined using NONMEM and Monte Carlo simulation was performed to evaluate the exposures of different dosing regimens. The PK analyses included 342 steady-state concentrations and a two-compartment model was optimal for polymyxin B PK data modelling. In the final model, creatinine clearance (CLCR ) was the significant covariate on CL (typical value 1.27 L/h; between-subject variability 15.1%) and ECMO did not show a significant impact on the polymyxin B PK. Additionally, we found that the PK parameter estimates of patients with and without ECMO support were mostly similar. Based on Monte Carlo simulations, the dose escalation of polymyxin B in patients with increased CLCR improved the probability of achieving required exposure. For patients with CLCR ≤ 120 ml/min, a dosage regimen of 100 mg every 12 h may represent the optimal regimen at an MIC of 1 mg/L. The impact of ECMO on the polymyxin B PK is likely to be minimal. Our study showed a potential relationship between CLCR and polymyxin B CL, and the dose of polymyxin B should be adjusted in patients with increased CLCR .


  • Open Access

    Population Pharmacokinetics of Caspofungin among Extracorporeal Membrane Oxygenation Patients during the Postoperative Period of Lung Transplantation

    by Qianlin Wang, Zhu Zhang, Donglin Liu, Wenqian Chen, Gang Cui, Pengmei Li, Xianglin Zhang, Min Li, Qingyuan Zhan, Chen Wang

    Little is known about the influence of extracorporeal membrane oxygenation (ECMO) on the pharmacokinetics (PK) of caspofungin. The aim of this study was to describe population PK of caspofungin in patients with and without ECMO during the postoperative period of lung transplantation (LTx) and to investigate covariates influencing caspofungin PK. We compared ECMO patients with non-ECMO patients, and patients before and after ECMO weaning as self-controls, to analyzed changes in caspofungin PK. Eight serial blood samples were collected from each patient for PK analysis.